tm logo
ZYCLARA
Live/Registered
REGISTERED AND RENEWED

on 11 Jul 2023

Last Applicant/ Owned by

400 Somerset Corporate Blvd.

Bridgewater

NJ

08807

Serial Number

85721208 filed on 05th Sep 2012

Registration Number

4280040 registered on 22nd Jan 2013

in the Principal Register

Correspondent Address

Jeremy Blackowicz

Bausch Health Companies

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

ZYCLARA

Color is not claimed as a feature of the mark. Pharmaceutical preparations, namely, immunomodulators The mark consists of a triangle with straight lines in the center of each side of the triangle to give it a three dimensional appearance and the word "ZYCLARA".

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations, namely, immunomodulators


First Use Date in General

19th Apr 2010

First Use Date in Commerce

19th Apr 2010

Mark Details


Serial Number

No 85721208

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.05.02 -

Plain single line triangles

Description of Design Search

The mark consists of a triangle with straight lines in the center of each side of the triangle to give it a three dimensional appearance and the word "ZYCLARA".

Legal History


Show more

Status DateAction Taken
11th Jul 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11th Jul 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11th Jul 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11th Jul 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
28th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
15th Dec 2022TEAS SECTION 8 & 9 RECEIVED
14th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
22nd Aug 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22nd Aug 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Aug 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED